Active Lifestyles And New Surgical Techniques Driving Sports Medicine Market
Although the US sports medicine market is dominated by conservative care treatments, new surgical techniques, arthroscopy products and surgical implants are fueling growth in the market, which is projected to reach almost $15.5 billion by 2018. Industry consolidation and dealmaking among orthopedic manufacturers has yielded several partnerships and M&As that have included a sports medicine element.
You may also be interested in...
Market Intel: EU Ortho Close-Up: Rising, But Varying Orthopedic/Spinal Opportunities In 5 European Markets
A rising and more active aging population, and a growing incidence of osteoporosis fractures and back pain – as well as other spine-related issues – are paving the way for companies to bring innovative devices into the hands of orthopedic and spinal surgeons in Spain, Italy, Germany, the UK and France. In this feature, we take a closer look at the prevailing surgical approaches and techniques for selected fracture fixation, spinal surgery procedures, joint replacement, and arthroscopy procedures in each of the five major EU countries, as outlined in a new Meddevicetracker report. We also take a deep dive into the various growth opportunities of select procedures in each EU market and discuss trends.
Innovation Is Alive And Well In Sports Medicine
The sports medicine market comprises a number of product segments, many of which span several different orthopedics specialties.This space is expected to experience strong growth going forward as companies develop innovative ways, including some lower-cost approaches, to treat the joint and soft-tissue injuries commonly suffered by athletes and other sports enthusiasts.
Pink Sheet Podcast: Moderna CEO On Capitol Hill, Xtandi March-In Rights, Tofersen Adcomm In ALS
Pink Sheet reporter and editors discuss Moderna CEO’s Stéphane Bancel’s defense of his company and COVID-19 vaccine pricing at the Senate Health, Education, Labor and Pensions Committee, the NIH denying a petition to use government march-in rights for Xtandi, and Tofersen receiving a positive US FDA advisory committee recommendation for use in ALS.